- Investor Relations Asia Pacific

WuXi Biologics (Cayman) Inc.
(Incorporated in the Cayman Islands with limited liability)

Press Releases       

Please download the latest "Acrobat Reader" to view the PDF.

  • 2019-March-20
  • WuXi Biologics Receives EMA GMP Certificates (in PDF)
  • 2019-March-18
  • WuXi Biologics Continues to Deliver Record Results, 56.6% Year-on-Year Revenue Growth to RMB2,534.5 Million Net Profit 249.6% of Same Period Last Year to MB630.5 Million, Adjusted Net Profit 173.6% of Same Period Last Year to RMB751.5 Million, Total Backlog Surged 146.2% to US$3.6 Billion (in PDF)
  • 2019-January-16
  • Press Release (Chinese Version) (in PDF)
  • 2018
  • 2018 Press Releases
  • 2017
  • 2017 Press Releases

  • Company's Index

  • About   |   Terms of Use   |   Disclaimer
    © Copyright 1996-2019 Ltd. All rights reserved.
    DISCLAIMER: Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall Ltd. be liable for damages resulting from the use of the information provided on this website.